ICU Medical, Inc. (ICUI) Q1 2026 Earnings Call Transcript

ICU Medical, Inc. (ICUI) Q1 2026 Earnings Call Transcript

Seeking Alpha • May 8, 2026

Implied Volatility Surging for ICU Medical Stock Options

Investors need to pay close attention to ICUI stock based on the movements in the options market lately.

Zacks Investment Research • May 8, 2026

ICU Medical Announces First Quarter 2026 Results

SAN CLEMENTE, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended March 31, 2026.

GlobeNewsWire • May 7, 2026

ICU Medical (ICUI) Tops Q1 Earnings and Revenue Estimates

ICU Medical (ICUI) came out with quarterly earnings of $1.97 per share, beating the Zacks Consensus Estimate of $1.78 per share. This compares to earnings of $1.72 per share a year ago.

Zacks Investment Research • May 8, 2026

Madison Small Cap Fund Q1 2026 Portfolio Activity

ICU Medical's new high-volume pump has more connected features, which we believe will drive retention rates and incremental revenue. SiteOne Landscape Supply controls 18% of this $26 billion industry and has been growing revenue at a low double-digit compound annual growth rate over the past several years. Madison Small Cap Fund liquidated its position in Globus Medical after a multi-year period because the company's success drove its market cap to $12B.

Seeking Alpha • May 5, 2026

ICU Medical (ICUI) Reports Next Week: Wall Street Expects Earnings Growth

ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research • Apr 30, 2026

ICU Medical Announces Time of First Quarter 2026 Earnings Conference Call

SAN CLEMENTE, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2026 earnings release and conference call.

GlobeNewsWire • Apr 23, 2026

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ICU Medical, Inc. (NASDAQ: ICUI)

NEW YORK, April 16, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating ICU Medical, Inc. (NASDAQ: ICUI) on behalf of the company's shareholders.  The investigation seeks to determine whether ICU Medical's directors breached their fiduciary duties in connection with recent corporate actions.

PRNewsWire • Apr 16, 2026

ICU Medical Moving Toward A Cleaner Margin Leverage And Capital Return Story

ICU Medical is positioned for margin expansion as Smiths Medical integration and remediation costs subside, with upcoming product launches supporting growth. ICUI is gaining share in infusion pumps and consumables, leveraging product differentiation and rebounding from past compliance issues. Management targets net debt/EBITDA below 2.0x, opening the door for increased capital returns via buybacks or dividends within a couple of years.

Seeking Alpha • Apr 10, 2026

ICU Medical to Participate in Upcoming Investor Conferences

SAN CLEMENTE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences:

GlobeNewsWire • Feb 23, 2026